期刊文献+
共找到29篇文章
< 1 2 >
每页显示 20 50 100
Exosomal miR-224-3p promotes lymphangiogenesis and lymph node metastasis by targeting GSK3B in gastric cancer
1
作者 ZHENGYANG ZHOU LEI QIAO +6 位作者 TONGTONG WANG WEN PAN JINGJING DUAN HAIYANG ZHANG ting deng YI BA YI HE 《Oncology Research》 2025年第2期327-345,共19页
Background:Patients with gastric cancer(GC)are prone to lymph node metastasis(LNM),which is an important factor for recurrence and poor prognosis of GC.Nowadays,more and more studies have confirmed that exosomes can p... Background:Patients with gastric cancer(GC)are prone to lymph node metastasis(LNM),which is an important factor for recurrence and poor prognosis of GC.Nowadays,more and more studies have confirmed that exosomes can participate in tumor lymphangiogenesis.An in-depth exploration of the pathological mechanism in the process of LNM in GC may provide effective targets and improve the diagnosis and treatment effect.Materials and Methods:We used sequencing analysis of collected serum to screen out exo-miRNA related to LNM in GC.ELISA,qRT-PCR,Western Blot,RNA pull-down assay,Transwell assay,animal experiments,and other experiments were used to verify the results.Results:In this study,we screened out miR-224-3p related to GC progression and LNM in a vascular endothelial growth Factor C(VEGFC)-independent manner.We found that exo-miR-224-3p derived from GC cells could enter human lymphatic endothelial cells(HLECs)and promote the tube formation and migration of HLECs.In addition,it was revealed that miR-224-3p could bind to the 3′UTR region of GSK3B mRNA.Then,we proved that inhibiting the expression of GSK3B could suppress the phosphorylation ofβ-catenin and promote the transcription of PROX1,thus leading to tumor lymphangiogenesis.Furthermore,it was also found that hnRNPA1 mediated the sorting of miR-224-3p into exosomes,and the high expression of PKM2 promoted the secretion of exomiR-224-3p.Conclusions:Our discovery of the exo-miR-224-3p/GSK3B/β-catenin/PROX1 axis may provide a new direction for the clinical treatment of GC. 展开更多
关键词 Gastric cancer(GC) Extracellular vesicles(EVs) miR-224-3p Lymph node metastasis(LNM) GSK3B
暂未订购
Non-stationary response of complex ecosystem service networks to urbanization:Evidence from a typical eco-fragile area in China
2
作者 Zhen Shen Yang Gao +3 位作者 Lei Wang Zheyi Xia Haowei Liu ting deng 《Geography and Sustainability》 2025年第1期170-184,共15页
Understanding the complex interactions between urbanization and ecosystem services(ESs)is crucial for optimiz ing planning policies and achieving sustainable urban management.While previous research has largely focuse... Understanding the complex interactions between urbanization and ecosystem services(ESs)is crucial for optimiz ing planning policies and achieving sustainable urban management.While previous research has largely focused on highly urbanized areas,little attention has been given to the phased effect of progressive urbanization on ES networks.This study proposes a conceptual framework that utilizes the network method and space-time replace ment to examine the effect of urbanization on the complex relationships among ESs at different stages,with a particular emphasis on the progressive evolution of the process.We apply this framework to the Horqin area,a typical eco-fragile area in China.Results demonstrate that the connectivity of the ES synergy network exhibits a non-stationary characteristic,initially increasing,then decreasing,and subsequently strengthening.Meanwhile,its modularity shows a rising trend during periods of accelerated urbanization.The performance of the trade off network displays the opposite pattern.Additionally,we observe a gradual replacement of provisioning and regulation services by cultural services in terms of dominance in the synergy network as urbanization advances.By providing guidance for identifying key planning initiatives and implementing ecological protection policies at different stages of development,this study contributes a pathway that can inform development strategies in other regions undergoing progressive urbanization. 展开更多
关键词 Ecosystem services URBANIZATION Network analysis Non-stationary fluctuation
在线阅读 下载PDF
Exosomal miR-155 from gastric cancer induces cancerassociated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C/EPBβ 被引量:3
3
作者 Ying Liu Meng Wang +6 位作者 ting deng Rui Liu Tao Ning Ming Bai Guoguang Ying Haiyang Zhang Yi Ba 《Cancer Biology & Medicine》 SCIE CAS CSCD 2022年第9期1301-1314,共14页
Objective:The aim of this research was to identify whether exosomes were involved in impairing adipogenesis in cancer-associated cachexia(CAC)by detecting the adipodifferentiation capacity and the expressions of adipo... Objective:The aim of this research was to identify whether exosomes were involved in impairing adipogenesis in cancer-associated cachexia(CAC)by detecting the adipodifferentiation capacity and the expressions of adipogenic proteins in gastric cancer(GC)-associated adipocytes.Methods:Western blotting and RT-PCR were used to investigate the expressions of C/EPBβ,C/EPBα,PPARγ,and UCP1 in adipose mesenchymal stem cells(A-MSCs)to evaluate the function of exosomal miR-155.BALB/c nude mice were intravenously injected in vivo with GC exosomes with different levels of miR-155 to determine changes in adipodifferentiation of A-MSCs.Results:Exosomes derived from GC cells suppressed adipogenesis in A-MSCs as characterized by decreased lipid droplets.Similarly,A-MSCs co-cultured with GC exosomes exhibited increased ATP production through brown adipose differentiation characterized by highly dense mitochondria and enhanced UCP1 expression(P<0.05).Mechanistically,exosomal miR-155 secreted from GC cells suppressed adipogenesis and promoted brown adipose differentiation by targeting C/EPBβ,accompanied by downregulated C/EPBαand PPARγand upregulated UCP1(P<0.05).Moreover,overexpression of miR-155 in GC exosomes improved CAC in vivo,which was characterized by fat loss,suppressed expressions of C/EPBβ,C/EPBα,and PPARγin A-MSCs,and high expression of UCP1(P<0.05).Decreasing the level of miR-155 in injected GC exosomes abrogated the improved CAC effects.Conclusions:GC exosomal miR-155 suppressed adipogenesis and enhanced brown adipose differentiation in A-MSCs by targeting C/EPBβof A-MSCs,which played a crucial role in CAC. 展开更多
关键词 Exosomes adipose mesenchymal stem cells MIR-155 CACHEXIA gastric cancer
暂未订购
Reinventing the mechanism of high-performance Bi anode in aqueous K^+ rechargeable batteries 被引量:3
4
作者 tingting Qin Xuefeng Chu +10 位作者 ting deng Boran Wang Xiaoyu Zhang Taowen Dong Zhengming Li Xiaofeng Fan Xin Ge Zizhun Wang Peng Wang Wei Zhang Weitao Zheng 《Journal of Energy Chemistry》 SCIE EI CAS CSCD 2020年第9期21-28,I0002,共9页
Increasing attention has been paid to rechargeable aqueous batteries due to their high safety and low cost.However,they remain in their infancy because of the limited choice of available anode materials with high spec... Increasing attention has been paid to rechargeable aqueous batteries due to their high safety and low cost.However,they remain in their infancy because of the limited choice of available anode materials with high specific capacity and satisfying cycling performance.Bi metal with layered structure can act as an ideal anode material with high capacity;however,the energy storage mechanism has not well elucidated.Herein,we demonstrate that Bi metal enables affording ultra-high specific capacity(254.3 mAh g^-1),superior rate capability and a capacity retention of 88.8%after 1600 cycles.Different from the previously-reported redox reaction mechanisms of Bi electrode,efficient(de)alloying of K+is responsible for its excellent performance.An excellent aqueous Bi battery is fabricated by matching Bi anode with Co(OH)2 cathode in KOH(1 M)electrolyte.Its outstanding performance is quite adequate and competitive for electrochemical energy storage devices. 展开更多
关键词 Aqueous rechargeable batteries Bi anode K^+ ALLOYING MECHANISM
在线阅读 下载PDF
Diffusionless-Like Transformation Unlocks Pseudocapacitance with Bulk Utilization: Reinventing Fe_(2)O_(3) in Alkaline Electrolyte 被引量:2
5
作者 Taowen Dong Wencai Yi +10 位作者 ting deng tingting Qin Xianyu Chu He Yang Lirong Zheng Seung Jo Yoo Jin-Gyu Kim Zizhun Wang Yan Wang Wei Zhang Weitao Zheng 《Energy & Environmental Materials》 SCIE EI CAS CSCD 2023年第1期145-154,共10页
Energy density can be substantially raised and even maximized if the bulk of an electrode material is fully utilized.Transition metal oxides based on conversion reaction mechanism are the imperative choice due to eith... Energy density can be substantially raised and even maximized if the bulk of an electrode material is fully utilized.Transition metal oxides based on conversion reaction mechanism are the imperative choice due to either constructing nanostructure or intercalation pseudocapacitance with their intrinsic limitations.However,the fully bulk utilization of transition metal oxides is hindered by the poor understanding of atomic-level conversion reaction mechanism,particularly it is largely missing at clarifying how the phase transformation(conversion reaction)determines the electrochemical performance such as power density and cyclic stability.Herein,α-Fe_(2)O_(3) is a case provided to claim how the diffusional and diffusionless transformation determine the electrochemical behaviors,as of its conversion reaction mechanism with fully bulk utilization in alkaline electrolyte.Specifically,the discharge productα-FeOOH diffusional from Fe(OH)2 is structurally identified as the atomic-level arch criminal for its cyclic stability deterioration,whereas the counterpartδ-FeOOH is theoretically diffusionless-like,unlocking the full potential of the pseudocapacitance with fully bulk utilization.Thus,such pseudocapacitance,in proof-of-concept and termed as conversion pseudocapacitance,is achieved via diffusionless-like transformation.This work not only provides an atomic-level perspective to reassess the potential electrochemical performance of the transition metal oxides electrode materials based on conversion reaction mechanism but also debuts a new paradigm for pseudocapacitance. 展开更多
关键词 bulk utilization conversion pseudocapacitance diffusionless transformation Fe_(2)O_(3) phase transformation
在线阅读 下载PDF
Gastric cancer secreted miR 214-3p inhibits the anti-angiogenesis effect of apatinib by suppressing ferroptosis in vascular endothelial cells 被引量:5
6
作者 WEIXUE WANG TONGTONG WANG +3 位作者 YAN ZHANG ting deng HAIYANG ZHANG YI BA 《Oncology Research》 SCIE 2024年第3期489-502,共14页
Diferent from necrosis,apoptosis,autophagy and other forms of cell death,ferroptosis is a mechanism that catalyzes lipid peroxidation of polyunsaturated ftty acids under the action of iron divalent or lipoxygenase,lea... Diferent from necrosis,apoptosis,autophagy and other forms of cell death,ferroptosis is a mechanism that catalyzes lipid peroxidation of polyunsaturated ftty acids under the action of iron divalent or lipoxygenase,leading to cell death.Apatinib is currently used in the third line standard treatment of advanced gastric cancer,targeting the anti-angiogenesis pathway.However,Apatinib mediated ferroptosis in vascular endothelial cells has not been reported yet.Tumor.secreted exosomes can be taken up into target cells to regulate tumor development,but the mechanism related to vascular endothelial cell ferroptosis has not yet been discovered.Here,we show that exosomes secreted by gastric cancer cells carry miR-214.3p into vascular endothelial cells and directdy target zinc finger protein A20 to negatively regulate ACSL4,a key enzyme of lipid peroxidation during frroptosis thereby inhibiting ferroptosis in vascular endothelial cells and reducing the eficiency of Apatinib.In conclusion,inhibition of miR-214-3p can increase the sensitivity of vascular endothelial cells to Apatinib,thereby promoting the antiangiogenic efect of Apatinib,suggesting a potential combination therapy for advanced gastric cancer. 展开更多
关键词 Cellular ferroptosis EXOSOME Tyrosine kinase inhibitor Gastrointestinal tumors miRNA
暂未订购
The design and engineering strategies of metal tellurides for advanced metal-ion batteries
7
作者 Wenmiao Zhao Xiaoyuan Shi +3 位作者 Bo Liu Hiroshi Ueno ting deng Weitao Zheng 《Journal of Energy Chemistry》 SCIE EI CAS CSCD 2024年第2期579-598,I0013,共21页
Owning various crystal structures and high theoretical capacity,metal tellurides are emerging as promising electrode materials for high-performance metal-ion batteries(MBs).Since metal telluride-based MBs are quite ne... Owning various crystal structures and high theoretical capacity,metal tellurides are emerging as promising electrode materials for high-performance metal-ion batteries(MBs).Since metal telluride-based MBs are quite new,fundamental issues raise regarding the energy storage mechanism and other aspects affecting electrochemical performance.Severe volume expansion,low intrinsic conductivity and slow ion diffusion kinetics jeopardize the performance of metal tellurides,so that rational design and engineering are crucial to circumvent these disadvantages.Herein,this review provides an in-depth discussion of recent investigations and progresses of metal tellurides,beginning with a critical discussion on the energy storage mechanisms of metal tellurides in various MBs.In the following,recent design and engineering strategies of metal tellurides,including morphology engineering,compositing,defect engineering and heterostructure construction,for high-performance MBs are summarized.The primary focus is to present a comprehensive understanding of the structural evolution based on the mechanism and corresponding effects of dimension control,composition,electron configuration and structural complexity on the electrochemical performance.In closing,outlooks and prospects for future development of metal tellurides are proposed.This work also highlights the promising directions of design and engineering strategies of metal tellurides with high performance and low cost. 展开更多
关键词 Metal tellurides Metal-ion battery Energy storage mechanism Material design and engineering
在线阅读 下载PDF
RXRα modulates hepatic stellate cell activation and liver fibrosis by targeting CaMKKβ–AMPKα axis
8
作者 Lijun Cai Meimei Yin +23 位作者 Shuangzhou Peng Fen Lin Liangliang Lai Xindao Zhang Lei Xie Chuanying Wang Huiying Zhou Yunfeng Zhan Gulimiran Alitongbieke Baohuan Lian Zhibin Su Tenghui Liu Yuqi Zhou Zongxi Li Xiaohui Chen Qi Zhao ting deng Lulu Chen Jingwei Su Luoyan Sheng Ying Su Ling-Juan Zhang Fu-Quan Jiang Xiao-Kun Zhang 《Acta Pharmaceutica Sinica B》 2025年第7期3611-3631,共21页
Hepatic stellate cells(HSCs)are the primary fibrogenic cells in the liver,and their activation plays a crucial role in the development and progression of hepatic fibrosis.Here,we report that retinoid X receptor-alpha(... Hepatic stellate cells(HSCs)are the primary fibrogenic cells in the liver,and their activation plays a crucial role in the development and progression of hepatic fibrosis.Here,we report that retinoid X receptor-alpha(RXRα),a unique member of the nuclear receptor superfamily,is a key modulator of HSC activation and liver fibrosis.RXRαexerts its effects by modulating calcium/calmodulin-dependent protein kinase kinaseβ(CaMKKβ)-mediated activation of AMP-activated protein kinase-alpha(AMPKα).In addition,we demonstrate that K-80003,which binds RXRαby a unique mechanism,effectively suppresses HSC activation,proliferation,and migration,thereby inhibiting liver fibrosis in the CCl4 and amylin liver NASH(AMLN)diet animal models.The effect is mediated by AMPKαactivation,promoting mitophagy in HSCs.Mechanistically,K-80003 activates AMPKαby inducing RXRαto form condensates with CaMKKβand AMPKαvia a two-phase process.The formation of RXRαcondensates is driven by its N-terminal intrinsic disorder region and requires phosphorylation by CaMKKβ.Our results reveal a crucial role of RXRαin liver fibrosis regulation through modulating mitochondrial activities in HSCs.Furthermore,they suggest that K-80003 and related RXRαmodulators hold promise as therapeutic agents for fibrosis-related diseases. 展开更多
关键词 K-80003 RXRα AMPKα CaMKKβ HSCS Liver fibros
原文传递
Unlock the potential of Li4Ti5O(12) for high-voltage/long-cycling-life and high-safety batteries: Dual-ion architecture superior to lithium-ion storage 被引量:5
9
作者 Xiaoyuan Shi Shansheng Yu +2 位作者 ting deng Wei Zhang Weitao Zheng 《Journal of Energy Chemistry》 SCIE EI CAS CSCD 2020年第5期13-18,共6页
Li4Ti5O(12)(LTO)has drawn great attention due to its safety and stability in lithium-ion batteries(LIBs).However,high potential plateau at 1.5 V vs.Li reduces the cell voltage,leading to a limited use of LTO.Dual-ion ... Li4Ti5O(12)(LTO)has drawn great attention due to its safety and stability in lithium-ion batteries(LIBs).However,high potential plateau at 1.5 V vs.Li reduces the cell voltage,leading to a limited use of LTO.Dual-ion batteries(DIBs)can achieve high working voltage due to high intercalation potential of cathode.Herein,we propose a DIB configuration in which LTO is used as anode and the working voltage was 3.5 V.This DIB achieves a maximum specific energy of 140 Wh/kg at a specific power of 35 W/kg,and the specific power of 2933 W/kg can be obtained with a remaining specific energy of 11 Wh/kg.Traditional LIB material shows greatly improved properties in the DIB configuration.Thus,reversing its disadvantage leads to upgraded performance of batteries.Our configuration has also widened the horizon of materials for DIBs. 展开更多
关键词 Li4Ti5O12 SPECIFIC energy SPECIFIC power Dual-ion BATTERIES LITHIUM-ION BATTERIES
在线阅读 下载PDF
Integrated Co3O4/carbon fiber paper for high-performance anode of dual-ion battery 被引量:4
10
作者 Lu Sui Xiaoyuan Shi +5 位作者 ting deng He Yang Hongyan Liu Hong Chen Wei Zhang Weitao Zheng 《Journal of Energy Chemistry》 SCIE EI CAS CSCD 2019年第10期7-12,共6页
In dual-ion batteries (DIBs), energy storage is achieved by intercalation/de-intercalation of both cations and anions. Due to the mismatch between ion diameter and layer space of active materials, however, volume expa... In dual-ion batteries (DIBs), energy storage is achieved by intercalation/de-intercalation of both cations and anions. Due to the mismatch between ion diameter and layer space of active materials, however, volume expansion and exfoliation always occur for electrode materials. Herein, an integrated electrode Co3O4/carbon fiber paper (CFP) is prepared as the anode of DIB. As the Co3O4 nanosheets grow on CFP substrate vertically, it promotes the immersion of electrolyte and shortens the pathway for ionic transport. Besides, the strong interaction between Co3O4 and CFP substrate reduces the possibility of sheet exfoliation. An integrated-electrode-based DIB is therefore packaged using Co3O4/CFP as anode and graphite as cathode. As a result, a high energy density of 72 Wh/kg is achieved at a power density of 150 W/kg. The design of integrated electrode provides a new route for the development of high-performance DIBs. 展开更多
关键词 INTEGRATED electrode Dual-ion batteries CO3O4 ANODE Carbon fiber paper
在线阅读 下载PDF
Optimizing the micropore-to-mesopore ratio of carbon-fiber-cloth creates record-high specific capacitance 被引量:5
11
作者 Ying Zheng ting deng +1 位作者 Wei Zhang Weitao Zheng 《Journal of Energy Chemistry》 SCIE EI CAS CSCD 2020年第8期210-216,I0008,共8页
The application of commercial carbon fiber cloth(CFC) in energy storage equipment is limited by its low specific capacitance and energy density. By a simple one-step activation treatment, the specific surface area of ... The application of commercial carbon fiber cloth(CFC) in energy storage equipment is limited by its low specific capacitance and energy density. By a simple one-step activation treatment, the specific surface area of CFCs with porous structure can be increased considerably from 3.9 up to 875 m^2/g and the electrochemical properties of CFCs can be improved by three orders of magnitude(1324 mF/cm^2). Moreover,the hydrophobicity of CFCs can be transformed into superhydrophilicity. However, the electrochemical performance of CFCs does not show a positive correlation with specific surface area but have a strong relationship with the hierarchical pore distribution forged by the annealing treatment. Only moderate micropore and mesoporous ratio enables optimizing the electrochemical performance of CFCs. 展开更多
关键词 Pore distribution Hierarchical pores integration SUPERCAPACITORS Carbon fiber cloth Electrochemical performance
在线阅读 下载PDF
Toripalimab combined with targeted therapy and chemotherapy achieves pathologic complete response in gastric carcinoma:A case report 被引量:5
12
作者 Rui Liu Xia Wang +9 位作者 Zhi Ji ting deng Hong-Li Li Yan-Hui Zhang Yu-Chong Yang Shao-Hua Ge Le Zhang Ming Bai Tao Ning Yi Ba 《World Journal of Clinical Cases》 SCIE 2022年第18期6184-6191,共8页
BACKGROUND Neoadjuvant or perioperative chemotherapy combined with surgery can reduce postoperative recurrence and improve the long-term survival rate of patients with locally advanced resectable gastric carcinoma.Niv... BACKGROUND Neoadjuvant or perioperative chemotherapy combined with surgery can reduce postoperative recurrence and improve the long-term survival rate of patients with locally advanced resectable gastric carcinoma.Nivolumab combined with chemotherapy has been recommended by the National Comprehensive Cancer Network guidelines as a first-line therapy for advanced gastric carcinoma/adenocarcinoma of the gastroesophageal junction and serves as the basis for immunotherapy combined with chemotherapy to become a neoadjuvant therapy.Herein,we report a case in which pathologic complete response was achieved by neoadjuvant administration of toripalimab,Herceptin,and docetaxel,oxaliplatin,calcium folinate,and fluorouracil(FLOT)chemotherapy followed by surgery for human epidermal growth factor receptor 2(HER2)-and programmed deathligand 1(PD-L1)-positive locally advanced gastric carcinoma.We hope that this case will shed some light on neoadjuvant therapy for gastric carcinoma.CASE SUMMARY The patient was diagnosed with locally advanced adenocarcinoma of the cardia.Immunohistochemistry of the baseline tissues suggested that the tissues were HER2-(fluorescent in situ hybridization)and PD-L1-positive(combined positive score=1).The patient underwent surgery following a four-cycle neoadjuvant therapy comprising Herceptin,toripalimab,and FLOT chemotherapy.The postoperative pathological findings showed mild atypical hyperplasia of the local glands with chronic mucosal inflammation(proximal stomach),no clear residual tumor(tumor regression grade 0),no regional lymph node metastasis,and negative upper and lower cut ends.The levels of tumor markers were reduced to normal levels after re-examination.With good postoperative recovery,the four-cycle preoperative chemotherapy was continued at the same dosage as that previously administered.After the treatment,the patient was monitored every 3 mo with a follow-up of 12 mo(4 times).As of February 27,2022,he was in a good condition without disease progression.The clinical trial registration number is E2019401.CONCLUSION There are many ongoing studies on neoadjuvant immunotherapy combined with chemotherapy or radiotherapy;however,most of these studies are phase II studies with small cohorts.According to the results of some current studies,these combined regimens have shown promising results in terms of efficacy and safety.However,the clinical efficacy and safety of the neoadjuvant therapies used in these combined regimens need to be confirmed by additional prospective phase III clinical trials,and further exploration of molecular markers for effective populations is required. 展开更多
关键词 Toripalimab Targeted therapy CHEMOTHERAPY Perioperative management Gastric carcinoma Case report
暂未订购
肿瘤患者支持治疗的进展 被引量:6
13
作者 邓婷 巴一 《中国肿瘤临床》 CAS CSCD 北大核心 2022年第9期434-437,共4页
肿瘤支持治疗是与肿瘤放疗、化疗和手术并重的治疗手段。肿瘤支持治疗包括从肿瘤诊断开始一直到生命结束的全程,其内容相当宽泛,且对于延长患者生存期,改善生存质量,节约医疗成本等均具有重要意义。随着研究的不断深入,肿瘤支持治疗在... 肿瘤支持治疗是与肿瘤放疗、化疗和手术并重的治疗手段。肿瘤支持治疗包括从肿瘤诊断开始一直到生命结束的全程,其内容相当宽泛,且对于延长患者生存期,改善生存质量,节约医疗成本等均具有重要意义。随着研究的不断深入,肿瘤支持治疗在各领域均取得了一系列重要进展,其作用也越来越受到重视。尤为重要的是,医患认知从传统治疗理念发生根本性转变,使肿瘤支持治疗的发展前景焕发蓬勃生机。目前,肿瘤支持治疗逐渐向多学科整合、以患者为中心的个体化、全程化的管理及数字化方向发展。未来,随着学科分支的精细化和基础转化研究的不断深入,肿瘤患者的支持治疗必将形成一个完整的学科,造福广大的癌症患者。 展开更多
关键词 肿瘤 支持治疗 进展
暂未订购
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma 被引量:4
14
作者 Ming Bai Meng Wang +6 位作者 ting deng Yuxian Bai Kai Zang Zhanhui Miao Wenlin Gai Liangzhi Xie Yi Ba 《Cancer Biology & Medicine》 SCIE CAS CSCD 2022年第3期358-369,共12页
Objective:The mainstay treatment of esophageal squamous cell carcinoma(ESCC)involves chemotherapy and immunotherapy.However,alternative therapies are required for patients who are refractory or intolerant to existing ... Objective:The mainstay treatment of esophageal squamous cell carcinoma(ESCC)involves chemotherapy and immunotherapy.However,alternative therapies are required for patients who are refractory or intolerant to existing therapies.Methods:In this single-arm,multicenter,open-label phase Ib study,30 patients received an intravenous infusion of SCT200,an antiepidermal growth factor receptor(EGFR)monoclonal antibody,6.0 mg/kg once a week for 6 weeks,followed by 8.0 mg/kg once every 2 weeks until disease progression or intolerable toxicity.The primary endpoint was the objective response rate(ORR).The secondary endpoints were progression-free survival(PFS),overall survival(OS),and safety.Results:Thirty patients were enrolled between July 2018 and May 2019.The ORR was 16.7%(95%CI:5.6%–34.7%).The median PFS and OS were 3.1 months(95%CI:1.5–4.3)and 6.8 months(95%CI:4.7–10.1),respectively.A numerical difference without any statistical significance in ORR was observed in patients with different EGFR expressions(≥50%:25.0%vs.<50%:0%,P=0.140)or TP53 mutation abundance(<10%:23.8%vs.≥10%:0%,P=0.286).Improved median PFS(3.4 vs.1.4 months,P=0.006)and OS(8.0 vs.4.2 months,P=0.027)were associated with TP53 mutation abundance of<10%.The most common treatment-related adverse events of grade 3 or 4(occurring in≥2 patients)were hypomagnesemia[7(23.3%)]and rash[2(6.7%)].No treatmentrelated death occurred.Conclusions:SCT200 monotherapy as the second-or further-line treatment for advanced ESCC showed favorable efficacy,with an acceptable safety profile.TP53 mutation abundance might serve as a potential predictive biomarker. 展开更多
关键词 Epidermal growth factor receptor esophageal squamous cell carcinoma SCT200 monoclonal antibody
暂未订购
改良FOLFIRINOX方案一线化疗中国转移性胰腺癌患者的疗效与安全性研究 被引量:2
15
作者 Zhi‑Qiang Wang Fei Zhang +9 位作者 ting deng Le Zhang Fen Feng Feng‑Hua Wang Wei Wang De‑Shen Wang Hui‑Yan Luo Rui‑Hua Xu Yi Ba Yu‑Hong Li 《癌症》 SCIE CAS CSCD 2019年第8期377-384,共8页
背景与目的奥沙利铂(oxaliplatin)、伊立替康(irinotecan)、5-氟尿嘧啶(5-fluorouracil)和1-醛氢叶酸(l-leucovorin)联合用药(即FOLFIRINOX方案)已成为晚期胰腺癌(pancreatic cancer,PC)的一线治疗方案之一。然而,与FOLFIRINOX标准剂量... 背景与目的奥沙利铂(oxaliplatin)、伊立替康(irinotecan)、5-氟尿嘧啶(5-fluorouracil)和1-醛氢叶酸(l-leucovorin)联合用药(即FOLFIRINOX方案)已成为晚期胰腺癌(pancreatic cancer,PC)的一线治疗方案之一。然而,与FOLFIRINOX标准剂量相关的3级或4级不良事件的较高发生率限制了该方案在临床上的广泛应用。在本研究中,我们对改良FOLFIRINOX方案一线化疗中国转移性PC患者的疗效和安全性进行了评价。方法将组织学证实为原发转移性胰腺癌,且东部肿瘤协作组(Eastern Cooperative Oncology Group,ECOG)体能状态评分为0-2的患者纳入本研究。所有患者均接受改良FOLFIRINOX方案治疗(静脉滴注奥沙利铂65 mg/m^2、伊立替康150 mg/m^2、l-醛氢叶酸200 mg/m^2、5-氟尿嘧啶2400 mg/m^2,每2周重复1次)。治疗持续12个周期,除非患者出现疾病进展(progressive disease,PD)、症状恶化的疾病稳定(stable disease,SD)、不可耐受的不良事件或要求提前终止治疗。主要终点为客观缓解率(objective response rate,ORR)。结果2012年7月至2017年4月期间,共有来自3个机构的65例患者被纳入本研究。所有患者均接受了至少1个周期化疗,化疗周期中位数为8个周期(范围:1-12个周期)。本研究中未观察到完全缓解。21(32.3%)例患者为部分缓解,27(41.5%)例表现为SD。总体人群的ORR和疾病控制率(diseasecontrol rate,DCR)分别为32.3%和73.8%。中位总生存期和无进展生存期分别为11.60[95%置信区间(confidence interval,CI):8.76-14.44]个月和5.77(95%CI:5.00-6.54)个月。主要的3级或4级不良事件包括中性粒细胞减少(12.3%)和腹泻(6.2%)。未观察到与治疗相关的死亡。结论改良FOLFIRINOX具有良好的耐受性,可作为中国转移性PC中国患者的一线治疗方案。 展开更多
关键词 胰腺癌 转移 化疗 FOLFIRINOX 剂量调整 一线 多中心 总体缓解率 疗效 安全性
暂未订购
Architecture of Co-layered double hydroxide nanocages/graphene composite electrode with high electrochemical performance for supercapacitor 被引量:2
16
作者 Xianyu Chu ting deng +8 位作者 Wei Zhang Dong Wang Xiaofei Liu Cai Zhang tingting Qin Liyun Zhang Bingsen Zhang Chengmeng Chen Weitao Zheng 《Journal of Energy Chemistry》 SCIE EI CAS CSCD 2018年第2期507-512,共6页
A facile hydrolysis method was applied to fabricate high-performance Co-layered double hydroxide(LDH)nanocages/graphene composites for supercapacitors. The materials exhibit enhanced rate capability than the counter... A facile hydrolysis method was applied to fabricate high-performance Co-layered double hydroxide(LDH)nanocages/graphene composites for supercapacitors. The materials exhibit enhanced rate capability than the counterpart electrode free of graphene while maintaining a high specific capacitance. In addition,such Co-LDH nanocages/graphene composites display an excellent cycling stability; the capacitance retention of Co-LDH nanocages/graphene composite electrode remains 90.4% after 10000 cycles at a current density of 2 A g(-1). The integration of high capacity of double hydroxide and outstanding conductivity of graphene makes the delicately-designed composites promising candidates for electrode materials for supercapacitors. 展开更多
关键词 Co-LDH nanocages GRAPHENE HYDROLYSIS Rate capability SUPERCAPACITOR
在线阅读 下载PDF
Change of SPARC expression after chemotherapy in gastric cancer 被引量:2
17
作者 Yong-Yin Gao Ru-Bing Han +9 位作者 Xia Wang Shao-Hua Ge Hong-Li Li ting deng Rui Liu Ming Bai Li-Kun Zhou Xin-Yuan Zhang Yi Ba Ding-Zhi Huang 《Cancer Biology & Medicine》 SCIE CAS CSCD 2015年第1期33-40,共8页
Objective: The expression of tumor biomarkers may change after chemotherapy. However, whether secreted protein acidic and rich in cysteine (SPARC) expression changes after chemotherapy in gastric cancer (GC) is u... Objective: The expression of tumor biomarkers may change after chemotherapy. However, whether secreted protein acidic and rich in cysteine (SPARC) expression changes after chemotherapy in gastric cancer (GC) is unclear, qqais study investigated the influence of chemotherapy on SPARC expression in GC. Methods: Immunohistochemistry was used to analyze SPARC expression in 132 GC cases (including 54 cases with preoperative chemotherapy and 78 cases without preoperative chemotherapy). SPARC expression of postoperative specimens with and without preoperative chemotherapy was assessed to analyze the influence of chemotherapy on SPARC expression. Results: SPARC was highly expressed in GC compared with the desmoplastic stroma surrounding tumor cells and noncancerous tissues. High SPAKC expression was correlated with invasion depth, lymph node, and TNM stage. After chemotherapy, a lower proportion of high SPARC expression was observed in patients with preoperative chemotherapy than in the controls. For 54 patients with preoperative chemotherapy; gross type, histology, depth of invasion, lymph node, TNM stage, and SPARC expression were related to overall survival. Further multivariate analysis showed that lymph node, histology, and SPARC expression after chemotherapy were independent prognostic factors. Conclusiou: SPARC expression may change after chemotherapy in GC. SPARC expression should be reassessed for patients with GC after chemotherapy. 展开更多
关键词 Secreted protein acidic and rich in cysteine (SPARC) gastric cancer (GC) IMMUNOHISTOCHEMISTRY CHEMOTHERAPY
暂未订购
Increasing the range of non-noble-metal single-atom catalysts 被引量:5
18
作者 ting deng Weitao Zheng Wei Zhang 《Chinese Journal of Catalysis》 CSCD 北大核心 2017年第9期1489-1497,共9页
1.Introduction Catalysis[1]plays a vital role in the chemical industries,which affect our daily life.The preparation of suitable catalysts for the selective and efficient synthesis of desired products from raw materia... 1.Introduction Catalysis[1]plays a vital role in the chemical industries,which affect our daily life.The preparation of suitable catalysts for the selective and efficient synthesis of desired products from raw materials is important[2].Noble metals have long been widely used as commercial catalysts because of their incomparably high activities and stabilities in heterogeneous catalysis.However,the scarcity and corresponding high prices of noble metals will make it difficult to meet the increasing demands for such catalysts.Only the surface atoms of catalysts are involved in the catalytic process because of the low coordination environment and high activity,and much effort has been devoted to downsizing metal particles to decrease costs and enhance performance[3,4].The report in 2011 by Zhang and his group[5]of the first fabrication of a Pt single-atom catalyst(SAC)supported on iron oxide(Pt1/FeOx)and its high activity and stability in CO oxidation and preferential oxidation(PROX)of CO made SACs a practical reality(Fig.1)[6].Since then,SACs have become one of the main focuses of catalysis research,and much effort has been devoted to the study of noble-metal SACs[7–10].SACs provide single active sites,which give high activities and selectivities,and differ from those of conventional catalysts.They therefore could bridge the gap between homogeneous and heterogeneous catalysis.A review by Yang et al.[11]and some other papers[12–14]have summarized progress in the preparation,characterization,and performances of SACs in various reactions.However,the question arises as to whether non-noble metals have excellent catalytic properties when they are downsized to single atoms and can completely eliminate our dependence on scarce noble metals.The answer is optimistic and research in this area indicates a promising future. 展开更多
在线阅读 下载PDF
Efficacy and safety of KN026,a bispecific anti-HER2 antibody,in combination with KN046,an anti-CTLA4/PD-L1 antibody,in patients with advanced HER2-positive nonbreast cancer:a combined analysis of a phase Ⅰb and a phase Ⅱ study
19
作者 Dan Liu Jifang Gong +20 位作者 Jian Li Changsong Qi Zuoxing Niu Bo Liu Zhi Peng Suxia Luo Xicheng Wang Yakun Wang Rusen Zhao Lilin Chen ting deng Zhen Li Lei Chen Meimei Fang Hongwei Yang Linzhi Lu Yanming Zhang Fengling Kang ting Xu Xiaotian Zhang Lin Shen 《Signal Transduction and Targeted Therapy》 2025年第4期2412-2421,共10页
To evaluate the efficacy and safety of KN026,a novel bispecific HER2(ECD2 and ECD4)antibody,plus KN046,a PD-L1,and CTLA4 bispecific antibody,in patients with advanced HER2-positive solid tumors.We conducted two sequen... To evaluate the efficacy and safety of KN026,a novel bispecific HER2(ECD2 and ECD4)antibody,plus KN046,a PD-L1,and CTLA4 bispecific antibody,in patients with advanced HER2-positive solid tumors.We conducted two sequentially designed phase Ib and Il studies with similar target populations and evaluation schedules.The primary endpoints included safety,maximum tolerated dose(MTD),the recommended phase Il dose(RP2D)for the phase Ib study,and the objective response rate(ORR)and duration of response(DoR)for the phase llstudy.Hereby,we solely report the results from 113 nonbreast cancer patients.In phase Ib,MTD was not reached.Dose 3 was confirmed to be acceptable for the phase lIl study.An objective response has been exclusively observed in HER2-positive patients.Any grade treatment-related adverse events(TRAEs)were reported in 108(95.6%)patients.The most common TRAEs were infusion reactions(38.9%),anemia(37.2%),elevated AST(31.0%),and diarrhea(30.1%).Among the 108 patients evaluated for efficacy,the overall ORR was 55.6%(95%Cl,45.7%,65.1%).In the HER2-positive GC subgroup,38 patients received this regimen as the 1st-line treatment and 30 patients achieved an objective response,with an ORR of 78.9%(95%Cl,62.7%,90.4%).Among 27 pretreated patients,the ORR was 44.4%(95%Cl,25.5%,64.7%).In the other HER2-positive solid tumor subgroup(n=34),the ORR was 52.9%(95%CI 35.1%,70.2%).Thus,KN026 plus KN04 exhibits promising efficacy and acceptable safety profiles in HER2-positive nonbreast cancer,as does the 1st-line treatment for GC. 展开更多
关键词 kn phase ib il studies advanced her positive nonbreast cancer anti ctla pd l antibody bispecific anti her antibody safety phase Ib efficacy
暂未订购
上一页 1 2 下一页 到第
使用帮助 返回顶部